Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases (D-HEM)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Semmelweis University
Information provided by (Responsible Party):
Istvan Takacs, Semmelweis University Identifier:
First received: January 6, 2012
Last updated: November 18, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)